National Vision Holdings, Inc. (EYE) stock

EYENasdaqOphthalmic GoodsFiscal year ends January 2

Financials through Q3 FY2026, quarter ended Oct 3, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3039% below fair value

$18.30−0.27 (-1.48%)

Close on Nov 13, 2026Market cap $1.45BP/E 22.6Yield –

National Vision r&d expenses

Research and development expenses are spending on new products and technology.

National Vision has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in National Vision's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EYE.

Revenue growth7.0% · median 9.9%

Gross margin58.8% · median 69.7%

Operating margin5.1% · median 7.1%

Net margin3.2% · median 0.5%

Advertisement
300 × 250

See a number that looks wrong?